Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aye Aye Thike

Showing results (1-10 of 111) with videos related to

Pageof 12
Sort By:
Journal of Clinical Pathology|November 20, 2016
Identifying progression predictors of breast ductal carcinoma in situJoe Yeong, Aye Aye Thike, Puay Hoon Tan, et al.
Pathology|December 23, 2009
Diagnostic issues in second opinion consultations in prostate pathologyAna Richelia Jara-Lazaro, Aye Aye Thike, Puay Hoon Tan
Breast (Edinburgh, Scotland)|March 30, 2010
Utility of mammaglobin and gross cystic disease fluid protein-15 (GCDFP-15) in confirming a breast origin for recurrent tumorsShi Yun Chia, Aye Aye Thike, Poh Yian Cheok, et al.
Journal of Clinical Pathology|March 15, 2011
Histiocytoid breast carcinoma: an enigmatic lobular entityPuay Hoon Tan, Oi Harada, Aye Aye Thike, et al.
Singapore Medical Journal|April 18, 2021
Medullary breast carcinoma: a pathogenic review and immunohistochemical study using tissue microarrayMing Lee, Ana Richelia Jara-Lazaro, Poh Yian Cheok, et al.
Histopathology|January 21, 2014
Immunohistochemical expression of homeoproteins Six1 and Pax3 in breast phyllodes tumours correlates with histological grade and clinical outcomeWai Jin Tan, Aye Aye Thike, Boon Huat Bay, et al.
Breast Cancer Research and Treatment|February 14, 2015
Cancer stem cell and epithelial-mesenchymal transition markers predict worse outcome in metaplastic carcinoma of the breastMing Liang Oon, Aye Aye Thike, Sie Yong Tan, et al.
Journal of Clinical Pathology|December 6, 2014
CD1d expression in renal cell carcinoma is associated with higher relapse rates, poorer cancer-specific and overall survivalTsung Wen Chong, Fera Yiqian Goh, Mei Yi Sim, et al.
The American Journal of Surgical Pathology|July 21, 2016
Clinicopathologic Characteristics of Solid Papillary Carcinoma of the BreastBenjamin Yongcheng Tan, Aye Aye Thike, Ian O Ellis, et al.
Recent Patents on Anti-Cancer Drug Discovery|January 21, 2011
Therapeutic targets in triple negative breast cancer - where are we now?Yvonne H-F Teng, Aye-Aye Thike, Nan-Soon Wong, et al.
Pageof 12

Showing results (1-10 of 111) with videos related to

Sort By:
Pageof 12
Journal of Clinical Pathology|November 20, 2016
Identifying progression predictors of breast ductal carcinoma in situJoe Yeong, Aye Aye Thike, Puay Hoon Tan, et al.
Pathology|December 23, 2009
Diagnostic issues in second opinion consultations in prostate pathologyAna Richelia Jara-Lazaro, Aye Aye Thike, Puay Hoon Tan
Breast (Edinburgh, Scotland)|March 30, 2010
Utility of mammaglobin and gross cystic disease fluid protein-15 (GCDFP-15) in confirming a breast origin for recurrent tumorsShi Yun Chia, Aye Aye Thike, Poh Yian Cheok, et al.
Journal of Clinical Pathology|March 15, 2011
Histiocytoid breast carcinoma: an enigmatic lobular entityPuay Hoon Tan, Oi Harada, Aye Aye Thike, et al.
Singapore Medical Journal|April 18, 2021
Medullary breast carcinoma: a pathogenic review and immunohistochemical study using tissue microarrayMing Lee, Ana Richelia Jara-Lazaro, Poh Yian Cheok, et al.
Histopathology|January 21, 2014
Immunohistochemical expression of homeoproteins Six1 and Pax3 in breast phyllodes tumours correlates with histological grade and clinical outcomeWai Jin Tan, Aye Aye Thike, Boon Huat Bay, et al.
Breast Cancer Research and Treatment|February 14, 2015
Cancer stem cell and epithelial-mesenchymal transition markers predict worse outcome in metaplastic carcinoma of the breastMing Liang Oon, Aye Aye Thike, Sie Yong Tan, et al.
Journal of Clinical Pathology|December 6, 2014
CD1d expression in renal cell carcinoma is associated with higher relapse rates, poorer cancer-specific and overall survivalTsung Wen Chong, Fera Yiqian Goh, Mei Yi Sim, et al.
The American Journal of Surgical Pathology|July 21, 2016
Clinicopathologic Characteristics of Solid Papillary Carcinoma of the BreastBenjamin Yongcheng Tan, Aye Aye Thike, Ian O Ellis, et al.
Recent Patents on Anti-Cancer Drug Discovery|January 21, 2011
Therapeutic targets in triple negative breast cancer - where are we now?Yvonne H-F Teng, Aye-Aye Thike, Nan-Soon Wong, et al.
Pageof 12